B. Braun SE Overview
Pro stress-test →B. Braun SE is a medical technology company that manufactures medical devices and pharmaceutical products, including infusion pumps and systems, surgical instruments, suture materials, hip and knee implants, dialysis equipment and accessories, and ostomy, disinfection, and wound care products. Founded in 1839, the company remains family-owned by the Braun family and has over 63,000 employees worldwide operating offices and production facilities in more than 60 countries.
Strategic Profile
Pro stress-test →B. Braun operates through three divisions: Hospital Care (infusion, nutrition, pain therapy, and regional anesthesia focus), Aesculap (surgical and interventional treatment), and Avitum (renal care). The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety.
Competitive Landscape
Pro stress-test →B. Braun competes in a concentrated market dominated by Medtronic ($36.4B revenue), Johnson & Johnson ($33.8B), and Abbott ($30.3B). B. Braun differentiates through specialized product lines (infusion therapy, dialysis, regional anesthesia) and its integrated three-division structure across Hospital Care, surgical (Aesculap), and renal care (Avitum), targeting hospital and healthcare provider segments.
Industry Context
B. Braun SE operates in Medical devices and infusion therapy.
Key facts
Founded: 1839 · Headquarters: Melsungen, Germany · Employees: 63,000 · Revenue: €9.14B · Market cap: N/A